Chapel Hill, NC, United States of America

Dongfen Yuan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongfen Yuan. Retrieved from https://idiyas.com/inventor/dongfen-yuan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dongfen Yuan: Innovator in Biological Agent-Exosome Compositions

Introduction

Dongfen Yuan is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biological sciences, particularly in the development of innovative compositions that utilize exosomes for delivering biological agents to cells.

Latest Patents

Dongfen Yuan holds a patent for "Biological agent-exosome compositions and uses thereof." This invention relates to compositions comprising exosomes and biological agents, along with methods for using these compositions to effectively deliver biological agents to cells and subjects. He has 1 patent to his name.

Career Highlights

Dongfen Yuan is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance research in his field. His work focuses on the intersection of biology and technology, aiming to improve therapeutic delivery systems.

Collaborations

He has collaborated with notable colleagues, including Elena V Batrakova and Alexander Victorovich Kabanov, who share his commitment to innovation in biological research.

Conclusion

Dongfen Yuan's work exemplifies the potential of exosome technology in medicine, paving the way for future advancements in biological agent delivery systems. His contributions are vital to the ongoing evolution of therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…